Monthly information on share capital and company voting rights
Cellectis (Euronext Growth: CLLS) published its monthly report on share capital and voting rights as of Oct 31, 2025.
Key figures: Total number of shares = 100,325,454; Total number of voting rights = 89,406,760. The disclosure follows Article 223-16 of the French financial markets authority general regulation and lists investor and media contact details for further information.
Cellectis (Euronext Growth: CLLS) ha pubblicato il rapporto mensile sul capitale sociale e sui diritti di voto aggiornato al 31 ottobre 2025.
Principali dati: Numero totale di azioni = 100.325.454; Numero totale di diritti di voto = 89.406.760. La comunicazione è pubblicata in conformità all'articolo 223-16 del regolamento generale dell'Autorità des marchés financiers francese e riporta i contatti degli investitori e dei media per ulteriori informazioni.
Cellectis (Euronext Growth: CLLS) publicó su informe mensual sobre el capital social y los derechos de voto a fecha de 31 de octubre de 2025.
Cifras clave: Número total de acciones = 100.325.454; Número total de derechos de voto = 89.406.760. La divulgación se realiza conforme al artículo 223-16 del reglamento general de la Autoridad francesa de mercados financieros y detalla los contactos de inversores y medios para obtener más información.
Cellectis (Euronext Growth: CLLS)는 주식수 및 의결권에 관한 월간 보고서를 2025년 10월 31일 기준으로 발표했습니다.
주요 수치: 총 발행주식 수 = 100,325,454주; 총 의결권 수 = 89,406,760. 공시는 프랑스 금융시장감독청 일반 규정의 제223-16조에 따른 것으로, 추가 정보로 투자자 및 언론 연락처를 제공합니다.
Cellectis (Euronext Growth: CLLS) a publié son rapport mensuel sur le capital social et les droits de vote au 31 octobre 2025.
Chiffres clés : Nombre total d'actions = 100 325 454 ; Nombre total de droits de vote = 89 406 760. La divulgation est effectuée conformément à l'article 223-16 du règlement général de l'Autorité des marchés financiers française et indique les coordonnées des investisseurs et des médias pour de plus amples informations.
Cellectis (Euronext Growth: CLLS) hat seinen monatlichen Bericht über das Aktienkapital und die Stimmrechte zum 31. Oktober 2025 veröffentlicht.
Wichtige Kennzahlen: Gesamtanzahl der Aktien = 100.325.454; Gesamtanzahl der Stimmrechte = 89.406.760. Die Offenlegung erfolgt gemäß Artikel 223-16 der Allgemeinen Regulierung der französischen Finanzmarktauthorität und führt Kontaktdaten für Investoren und Medien für weitere Informationen auf.
سيليكتيس (إيونونيكت جروث: CLLS) نشرت تقريرها الشهرى عن رأس المال والسندات التصويت اعتباراً من 31 أكتوبر 2025.
الأرقام الرئيسية: إجمالي عدد الأسهم = 100,325,454؛ إجمالي عدد حقوق التصويت = 89,406,760. يتبع الكشف المادة 223-16 من التنظيم العام لهيئة الأسواق المالية الفرنسية ويدرج تفاصيل اتصال المستثمرين ووسائل الإعلام لمزيد من المعلومات.
- None.
- None.
(Article 223-16 of General Regulation of the French financial markets authority)
PARIS, Nov. 07, 2025 (GLOBE NEWSWIRE) --
Listing market: Euronext Growth
ISIN code: FR0010425595
| Date | Total number of shares in the capital | Total number of voting rights |
| 10/31/2025 | 100,325,454 | 89,406,760 |
For further information on Cellectis, please contact:
Media contacts:
Pascalyne Wilson, Director, Communications, +33 (0)7 76 99 14 33, media@cellectis.com
Patricia Sosa Navarro, Chief of Staff to the CEO, +33 (0)7 76 77 46 93
Investor Relations contact:
Arthur Stril, Chief Financial Officer & Chief Business Officer, investors@cellectis.com
Attachments
FAQ
What are Cellectis (CLLS) total shares as of October 31, 2025?
How many voting rights does Cellectis (CLLS) have on October 31, 2025?
Where is the Cellectis (CLLS) share capital and voting rights disclosure filed?
When was the Cellectis (CLLS) monthly capital report published?
Who should investors contact for questions about Cellectis (CLLS) voting rights?
Does the October 2025 report show any share issuance or cancellation figures for Cellectis (CLLS)?
